Literature DB >> 7886779

Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.

N C Hepburn1, M J Tidman, J A Hunter.   

Abstract

The efficacy of aminosidine was compared with sodium stibogluconate in an open, randomized study of parasitologically-proven cutaneous leishmaniasis in Belize. Aminosidine, 14 mg/kg/d (max. 1 g daily) for 20 d, healed 10 of 17 lesions and sodium stibogluconate, 20 mg/kg/d for 20 d, healed 15 of 17 lesions. Lesions caused by Leishmania braziliensis were relatively unresponsive to aminosidine. Aminosidine was well tolerated and toxicity was not observed. Sodium stibogluconate was not well tolerated and treatment was associated with bone marrow suppression and elevation of serum aminotransferases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7886779     DOI: 10.1016/0035-9203(94)90237-2

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  16 in total

Review 1.  Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 2.  Leishmaniasis.

Authors:  T V Piscopo; A C Mallia
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

Review 3.  An update on pharmacotherapy for leishmaniasis.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Expert Opin Pharmacother       Date:  2014-10-25       Impact factor: 3.889

4.  Anti-leishmanial and toxicity activities of some selected Iranian medicinal plants.

Authors:  Hamidreza Kheiri Manjili; Hamidreza Jafari; Ali Ramazani; Noushin Davoudi
Journal:  Parasitol Res       Date:  2012-08-09       Impact factor: 2.289

5.  In Vitro Sensitivity of Cutaneous Leishmania Promastigote Isolates Circulating in French Guiana to a Set of Drugs.

Authors:  Marine Ginouvès; Stéphane Simon; Mathieu Nacher; Magalie Demar; Bernard Carme; Pierre Couppié; Ghislaine Prévot
Journal:  Am J Trop Med Hyg       Date:  2017-02-06       Impact factor: 2.345

Review 6.  Leishmaniasis.

Authors:  Tonio V Piscopo; Charles Mallia Azzopardi
Journal:  Postgrad Med J       Date:  2007-02       Impact factor: 2.401

7.  Leishmaniasis of the lip diagnosed by lymph node aspiration and treated with a combination of oral ketaconazole and intralesional sodium stibogluconate.

Authors:  Biju Vasudevan; Ashish Bahal
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

Review 8.  Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update.

Authors:  Ludovic Reveiz; Ana Nilce Silveira Maia-Elkhoury; Rubén Santiago Nicholls; Gustavo Adolfo Sierra Romero; Zaida E Yadon
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

9.  Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials.

Authors:  Dae Hyun Kim; Hye Jin Chung; Joachim Bleys; Reza F Ghohestani
Journal:  PLoS Negl Trop Dis       Date:  2009-02-17

10.  Interventions for American cutaneous and mucocutaneous leishmaniasis.

Authors:  Mariona Pinart; José-Ramón Rueda; Gustavo As Romero; Carlos Eduardo Pinzón-Flórez; Karime Osorio-Arango; Ana Nilce Silveira Maia-Elkhoury; Ludovic Reveiz; Vanessa M Elias; John A Tweed
Journal:  Cochrane Database Syst Rev       Date:  2020-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.